Amber warning for the UK's access to new medicines post Brexit
Tuesday, June 27, 2017 - 08:52
in Mathematics & Economics
A new study explores the consequences of a British exit from the European Medicines Agency as a result of Brexit, and what this will mean for pharmaceutical regulation and future access to medicines for UK citizens.